Many studies have shown that SCFAs, especially butyrate, can enhance the expressions of TJPs, such as Claudin-1 and ZO-1 in the colon, which are significantly decreased in the intestines of IBD patients [72]. This evidence concerns the gene TJP1 and inflammatory bowel disease.